The anti-obesity effects of these compounds have been demonstrated to result from their inhibition of pancreatic lipase, in addition to their influence on the expression and secretion of various markers associated with different signaling pathways [44,61]. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.